Skip to main content

Advertisement

SpringerLink
Log in

Prognostic Value of Nuclear β-catenin Overexpression at Invasive Front in Colorectal Cancer for Synchronous Liver Metastasis

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

β-catenin plays an important role in colorectal tumorigenesis. Relatively little is known about the relationship between β-catenin overexpression and liver metastasis. The purpose of this study was to investigate whether nuclear β-catenin overexpression in colorectal cancer is associated with synchronous liver metastasis.

Methods

The β-catenin expression in tumor tissue from 486 patients with colorectal cancer was examined by immunohistochemistry. The relationship between nuclear β-catenin expression in colorectal cancers and liver metastatic lesions and other clinicopathological characteristics was analyzed. Univariate analysis and logistic multivariate regression analysis were adopted to discriminate risk factors of liver metastasis.

Results

Nuclear β-catenin overexpression at the invasive front of the primary tumor in patients with liver metastasis is more evident than that in patients without liver metastasis (71.5% vs. 29.3%; P < 0.001). Nuclear β-catenin expression in primary tumors had a positive correlation with that in the matched metastatic lesions (r = 0.499, P < 0.001). Univariate and multivariate analyses indicated that overexpression of nuclear β-catenin at the invasive front in colorectal cancer correlated with liver metastasis.

Conclusions

Overexpression of nuclear β-catenin at the invasive front in colorectal cancer is strongly associated with liver metastasis and may be a promising predictor of liver metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2004;54:8–29.

    Article  PubMed  Google Scholar 

  2. Laffer UT, Metzger U. Intraportal chemotherapy for colorectal hepatic metastases. World J Surg. 1995;19:246–51.

    Article  PubMed  CAS  Google Scholar 

  3. Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Inomata M, et al. Risk factors for early extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma. Hepatogastroenterology. 2005;52:1840–4.

    PubMed  Google Scholar 

  4. Barozzi C, Ravaioli M, D’Errico A, Grazi GL, Poggioli G, Cavrini G, et al. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer. 2002;94:647–57.

    Article  PubMed  CAS  Google Scholar 

  5. Kaio E, Tanaka S, Kitadai Y, Sumii M, Yoshihara M, Haruma K, et al. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology. 2003;64:61–73.

    Article  PubMed  CAS  Google Scholar 

  6. Iwaya K, Oikawa K, Semba S, Tsuchiya B, Mukai Y, Otsubo T, et al. Correlation between liver metastasis of the colocalization of actin-related protein 2 and 3 complex and WAVE2 in colorectal carcinoma. Cancer Sci. 2007;98:992–9.

    Article  PubMed  CAS  Google Scholar 

  7. Chen Z, Li M, Yuan Y, Wang Q, Yan L, Gu J. Cancer/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: a predictive panel. Dis Colon Rectum. 2010;53:31–8.

    Article  PubMed  Google Scholar 

  8. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC. The clinical significance of invasion of veins by rectal cancer. Br J Surg. 1980;67:439–42.

    Article  PubMed  CAS  Google Scholar 

  9. Yamazoe Y, Maetani S, Onodera H, Nishikawa T, Tobe T. Histopathological prediction of liver metastasis after curative resection of colorectal cancer. Surg Oncol. 1992;1:237–44.

    Article  PubMed  CAS  Google Scholar 

  10. Shiiki S, Fuchimoto S, Iwagaki H (1991) Clinicopathological study on colorectal cancer with synchronous liver metastasis. J Jpn Soc Coloproctol. l44: 1107–12.

    Google Scholar 

  11. Adachi Y, Inomata M, Kakisako K, Sato K, Shiraishi N, Kitano S. Histopathologic characteristics of colorectal cancer with liver metastasis. Dis Colon Rectum. 1999;42:1053–6.

    Article  PubMed  CAS  Google Scholar 

  12. De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, et al. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology. 1998;28:971–9.

    Article  PubMed  Google Scholar 

  13. Nanashima A, Yamaguchi H, Sawai T, Yasutake T, Tsuji T, Jibiki M, et al. Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: relationship to primary tumors and prognosis after hepatic resection. J Gastroenterol Hepatol. 1999;14:1004–9.

    Article  PubMed  CAS  Google Scholar 

  14. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 1993;53:4754–6.

    PubMed  CAS  Google Scholar 

  15. Nihei Z, Ichikawa W, Kojima K, Togo S, Miyanaga T, Hirayama R, et al. The positive relationship between the expression of CD44 variant 6 and prognosis in colorectal cancer. Surg Today. 1996;26:760–1.

    Article  PubMed  CAS  Google Scholar 

  16. Ohji Y, Yao T, Eguchi T, Yamada T, Hirahashi M, Iida M, et al. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Oncol Rep. 2007;17:525–30.

    PubMed  CAS  Google Scholar 

  17. Fujita S, Taniguchi H, Yao T, Shimoda T, Ueno H, Hirai T, et al. Multi-institutional study of risk factors of liver metastasis from colorectal cancer: correlation with CD10 expression. Int J Colorectal Dis. 2010;25:681–6.

    Article  PubMed  Google Scholar 

  18. Brabletz S, Schmalhofer O, Brabletz T. Gastrointestinal stem cells in development and cancer. J Pathol. 2009;217:307–17.

    Article  PubMed  CAS  Google Scholar 

  19. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells-an integrated concept of malignant tumor progression. Nat Rev Cancer. 2005;5:744–9.

    Article  PubMed  CAS  Google Scholar 

  20. Fodde R, Brabletz T. Wnt/β-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007;19:150–8.

    Article  PubMed  CAS  Google Scholar 

  21. Brabletz T, Jung A, Hermann K, Günther K, Hohenberger W, Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract. 1998;194:701–4.

    PubMed  CAS  Google Scholar 

  22. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA. 2001;98:10356–61.

    Article  PubMed  CAS  Google Scholar 

  23. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434:843–50.

    Article  PubMed  CAS  Google Scholar 

  24. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis: a look outside the nucleus. Science. 2000;287:1606–9.

    Article  PubMed  CAS  Google Scholar 

  25. Brembeck FH, Rosário M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of β-catenin. Curr Opin Genet Dev. 2006;16:51–9.

    Article  PubMed  CAS  Google Scholar 

  26. Pinto D, Clevers H. Wnt, stem cells and cancer in the intestine. Biol Cell. 2005;97:185–96.

    Article  PubMed  CAS  Google Scholar 

  27. Fodde R, Brabletz T. WNT/β-catenin signalling in cancer stemness and malignant behaviour. Cell Biol. 2007;19:150–8.

    CAS  Google Scholar 

  28. Pancione M, Forte N, Fucci A, Sabatino L, Febbraro A, Di Blasi A, et al. Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer. Hum Pathol. 2010;41:867–76.

    Article  PubMed  CAS  Google Scholar 

  29. Bandapalli OR, Dihlmann S, Helwa R, Macher-Goeppinger S, Weitz J, Schirmacher P, et al. Transcriptional activation of the beta-catenin gene at the invasion front of colorectal liver metastases. J Pathol. 2009;218:370–9.

    Article  PubMed  CAS  Google Scholar 

  30. Greene FL, Page DL. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002. p. 127–38.

  31. Romeo S, Bovée JV, Grogan SP, Taminiau AH, Eilers PH, Leton-Jansen AM, et al. Chondromyxoid fibroma resembles in vitro chondrogenesis, though differs in expression of signalling molecules. J Pathol. 2005;206:135–42.

    Article  PubMed  CAS  Google Scholar 

  32. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science. 1996;272:1023–6.

    Article  PubMed  CAS  Google Scholar 

  33. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science. 1997;275:1790–2.

    Article  PubMed  CAS  Google Scholar 

  34. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 1997;275:1784–7.

    Article  PubMed  CAS  Google Scholar 

  35. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997;275:1787–90.

    Article  PubMed  CAS  Google Scholar 

  36. Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, et al. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res. 1998;58:1021–6.

    PubMed  CAS  Google Scholar 

  37. Suzuki H, Masuda N, Shimura T, Araki K, Kobayashi T, Tsutsumi S, et al. Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma. Anticancer Res. 2008;28:1821–30.

    PubMed  Google Scholar 

  38. Zhang B, Ougolkov A, Yamashita K, Takahashi Y, Mai M, Minamoto T. beta-Catenin and ras oncogenes detect most human colorectal cancer. Clin Cancer Res. 2003;9:3073–9.

    PubMed  CAS  Google Scholar 

  39. Baldus SE, Mönig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, et al. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res. 2004;10:2790–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

All authors have no competing interest to declare. We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work. There is no professional or other personal interest of any nature or kind in any product, service, and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled “Prognostic Value of Nuclear β-catenin Overexpression at Invasive Front in Colorectal Cancer for Synchronous Liver Metastasis.”

Author information

Authors and Affiliations

  1. Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, People’s Republic of China

    Lin Wang MD, Lei Wang MD, Wenbin Yu MD, Guangyong Zhang MD, Bo Chen MD & Sanyuan Hu MD

  2. Breast Cancer Center, Shandong Tumor Hospital and Institute, Jinan, Shandong, People’s Republic of China

    Zhiyong Yu MD

  3. Department of Pathology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, People’s Republic of China

    Hongxia Cheng MD & Ying Liu MD

Authors
  1. Lin Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongxia Cheng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ying Liu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lei Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wenbin Yu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guangyong Zhang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bo Chen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhiyong Yu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sanyuan Hu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanyuan Hu MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, L., Cheng, H., Liu, Y. et al. Prognostic Value of Nuclear β-catenin Overexpression at Invasive Front in Colorectal Cancer for Synchronous Liver Metastasis. Ann Surg Oncol 18, 1553–1559 (2011). https://doi.org/10.1245/s10434-010-1519-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1519-9

Keywords

Search

Navigation